ArticleBreast cancer research : BCR2026

H-score and ERBB2 mRNA refine identification of HER2-low and HER2-ultralow breast cancer.

Guilherme Parisotto Sartori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.